Why BioMarin Pharmaceutical Inc. Roared 14% Higher in October – Motley Fool


Motley Fool
Why BioMarin Pharmaceutical Inc. Roared 14% Higher in October
Motley Fool
What: Shares of BioMarin Pharmaceutical (NASDAQ: BMRN ) , a biopharmaceutical company focused on developing therapies to treat rare and ultra-rare diseases and disorders, roared higher by 14% in October, based on data from S&P Capital IQ, after the …
Investment Analysts’ Recent Ratings Updates for BioMarin Pharmaceutical Intercooler
BioMarin Pharmaceutical Stock Rating Upgraded by Wells Fargo & Co. (BMRN)Ticker Report
Trader’s Buzzers – Alliance Data Systems (NYSE:ADS), BioMarin Techsonian (press release)
WallStreet Scope
all 6 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd